Treating Alzheimer’s Together: Options, Conversations, and Care Planning
PA Mast outlines the medications available for Alzheimer’s, including amyloid-targeting monoclonal antibodies and symptom-based treatments. He highlights how the right treatment depends on timing, risk profile, and patient preferences. Educating patients and care partners is key to ensuring realistic expectations and shared decision-making. This video reinforces that while treatments don’t cure Alzheimer’s, they may slow decline and improve quality of life.
Key Takeaways:
- Educate patients and their care partners on types of pharmacological therapies and used shared decision making.
- Focus on quality of life when setting expectations for pharmacological treatment.
Speaker
Click on the photo below to learn more about the speaker.
References and Additional Resources:
Farlow MR, Miller ML, Pejovic V. Treatment options in Alzheimer’s disease: maximizing benefit, managing expectations. Dement Geriatr Cogn Disord. 2008;25(5):408-422. doi:10.1159/000122962
Mattos MK, Gibson JS, Wilson D, Jepson L, Ahn S, Williams IC. Shared decision-making in persons living with dementia: A scoping review. Dementia. 2023;22(4):875-909. doi:10.1177/14713012231156976
Thangwaritorn S, Lee C, Metchikoff E, et al. A review of recent advances in the management of Alzheimer’s disease. Cureus. 2024;16(4):e58416. doi:10.7759/cureus.58416
Supported by
